Search
Search Results
##search.searchResults.foundPlural##
-
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
791PDF: 508HTML: 6293 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2148PDF: 2013HTML: 813 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1678PDF: 1105HTML: 151 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2661PDF: 1415HTML: 1867CoverLetter: 235 -
CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY
4729PDF: 1842HTML: 1527Figure 1: Age distribution of Pediatric cases: 263 -
CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES? Risk factors for incipient diabetes in thalassemia
1219PDF: 1439HTML: 187 -
-
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3497PDF: 1021HTML: 4963 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6541PDF: 2260HTML: 14171Untitled: 256figure: 231 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3817PDF: 2654HTML: 1693 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
5335PDF: 2073HTML: 11568Fig 1: 293Fig 2: 236Fig 3: 362Fig 4: 261Fig 5: 253Fig 6: 239Fig 7: 262Fig 8: 242 -
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1450PDF: 1122HTML: 4680 -
-
-
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
949PDF: 819HTML: 255 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2800PDF: 1268HTML: 292 -
FIRST TUNISIAN CLUSTER ADMISSIONS OF CRITICALLY ILL PATIENTS WITH MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) : Multisystem inflammatory syndrome in children (MIS-C)
1660PDF: 600HTML: 244 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3450PDF: 1353HTML: 2379 -
SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2483PDF: 994HTML: 1721 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1644PDF: 878Suppl. Files: 372Html: 175 -
ADVANCES IN THE TREATMENT OF MALARIA
2982PDF: 1380HTML: 6163 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3076PDF: 1460HTML: 3742Untitled: 260Untitled: 262Untitled: 220 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3195PDF: 1104HTML: 3351 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2376PDF: 1032HTML: 6870Figure 1: 218 -
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
2017PDF: 1071HTML: 404 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2095PDF: 883HTML: 2229Table 1: 234Table 2: 249Table 3: 245Table 4: 245Table 5: 250Tble 6: 239Cover Letter: 253Greene Tab.7: 257 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
859PDF: 717HTML: 140







